Last 7 days
3.2%
Last 30 days
6.3%
Last 90 days
13.9%
Trailing 12 Months
15.1%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
TMO | 218.8B | 44.9B | 1.80% | -2.69% | 31.44 | 4.87 | 14.55% | -9.94% |
A | 38.9B | 6.8B | -7.12% | -2.94% | 31.04 | 5.68 | 8.37% | 3.64% |
ILMN | 34.8B | 4.6B | 9.07% | -35.87% | -7.89 | 7.58 | 1.28% | -677.95% |
MTD | 32.3B | 3.9B | 0.30% | 5.82% | 37.04 | 8.24 | 5.43% | 13.46% |
BRKR | 11.1B | 2.5B | 6.34% | 15.12% | 37.56 | 4.4 | 4.67% | 7.04% |
MID-CAP | ||||||||
NEO | 2.1B | 509.7M | 26.37% | -5.44% | -14.51 | 4.11 | 5.24% | -1628.17% |
SMALL-CAP | ||||||||
PACB | 2.2B | 128.3M | 3.11% | -0.62% | -6.93 | 16.97 | -1.69% | -73.40% |
ADPT | 1.2B | 185.3M | -4.53% | -36.18% | -6.03 | 6.51 | 20.06% | 3.42% |
QTRX | 394.4M | 105.5M | -10.11% | -62.94% | -4.08 | 3.74 | -4.55% | -67.63% |
BNGO | 326.9M | 27.8M | -22.54% | -54.36% | -2.47 | 11.76 | 54.62% | -83.06% |
CDXS | 255.3M | 138.6M | -29.45% | -81.04% | -7.6 | 1.84 | 32.30% | -57.86% |
HBIO | 130.5M | 113.3M | 8.01% | -46.55% | -13.71 | 1.15 | -4.68% | -3204.17% |
CDXC | 123.0M | 72.0M | -3.51% | -34.52% | -7.46 | 1.71 | 6.82% | 39.11% |
EYPT | 77.7M | 42.4M | -38.54% | -82.46% | -0.99 | 1.83 | 30.40% | -43.67% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 1.0% | 2,531 | 2,506 | 2,476 | 2,458 | 2,418 |
Cost Of Revenue | 0.0% | 1,225 | 1,224 | 1,221 | 1,221 | 1,208 |
Gross Profit | 1.9% | 1,306 | 1,281 | 1,255 | 1,237 | 1,210 |
Operating Expenses | 2.2% | 873 | 854 | 846 | 817 | 796 |
S&GA Expenses | 1.9% | 607 | 596 | 593 | 575 | 561 |
R&D Expenses | 2.3% | 236 | 231 | 226 | 223 | 221 |
EBITDA | 0.6% | 503 | 500 | 480 | 505 | - |
EBITDA Margin | -0.4% | 0.20* | 0.20* | 0.19* | 0.21* | - |
Earnings Before Taxes | 0.4% | 414 | 412 | 392 | 402 | 394 |
EBT Margin | -0.6% | 0.16* | 0.16* | 0.16* | 0.16* | - |
Interest Expenses | - | 20.00 | - | - | - | - |
Net Income | 7.9% | 297 | 275 | 274 | 282 | 277 |
Net Income Margin | 6.8% | 0.12* | 0.11* | 0.11* | 0.11* | - |
Free Cahsflow | 22.5% | 145 | 119 | 114 | 176 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 8.2% | 3,612 | 3,337 | 3,385 | 3,551 | 3,650 |
Current Assets | 3.8% | 2,113 | 2,037 | 2,088 | 2,251 | 2,472 |
Cash Equivalents | 3.6% | 649 | 626 | 723 | 816 | 1,068 |
Inventory | 6.8% | 800 | 750 | 759 | 740 | 710 |
Net PPE | 15.5% | 487 | 422 | 395 | 404 | 406 |
Goodwill | 19.9% | 458 | 382 | 396 | 384 | 340 |
Current Liabilities | 5.7% | 914 | 865 | 818 | 881 | 939 |
LT Debt, Non Current | 5.6% | 1,201 | 1,137 | 1,171 | 1,205 | 1,222 |
Shareholder's Equity | 20.1% | 1,126 | 937 | 984 | 1,031 | 1,071 |
Retained Earnings | - | 1,660 | - | - | - | - |
Additional Paid-In Capital | - | 238 | - | - | - | - |
Shares Outstanding | -0.2% | 147 | 147 | 148 | 149 | 151 |
Minority Interest | 8.2% | 12.00 | 11.00 | 14.00 | 14.00 | 14.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | 13.6% | 274 | 242 | 196 | 262 | 282 |
Share Based Compensation | -2.1% | 28.00 | 28.00 | 27.00 | 21.00 | 17.00 |
Cashflow From Investing | -66.7% | -251 | -150 | -141 | -270 | -192 |
Cashflow From Financing | -1754.6% | -415 | 25.00 | 105 | 139 | 319 |
Dividend Payments | 4.9% | 30.00 | 28.00 | 27.00 | 26.00 | 24.00 |
Buy Backs | -17.4% | 265 | 321 | 248 | 226 | 153 |
62.7%
37.7%
5.4%
Y-axis is the maximum loss one would have experienced if Bruker was unfortunately bought at previous high price.
15.3%
16.1%
21.4%
30.2%
FIve years rolling returns for Bruker.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -28.23 | -125,320 | 1,532,680 | -% |
2023-03-06 | Rockefeller Capital Management L.P. | unchanged | - | 160,000 | 714,000 | -% |
2023-02-28 | Voya Investment Management LLC | reduced | -16.7 | 727,022 | 10,677,000 | 0.01% |
2023-02-22 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | unchanged | - | 243,000 | 1,087,000 | 0.01% |
2023-02-21 | KB FINANCIAL PARTNERS, LLC | unchanged | - | - | - | -% |
2023-02-21 | NORTHWESTERN MUTUAL INVESTMENT MANAGEMENT COMPANY, LLC | reduced | -7.48 | 281,249 | 1,745,250 | 0.05% |
2023-02-21 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | sold off | -100 | -2,000 | - | -% |
2023-02-21 | MACQUARIE GROUP LTD | sold off | -100 | -153,000 | - | -% |
2023-02-17 | Linden Thomas Advisory Services, LLC | new | - | 1,086,560 | 1,086,560 | 0.31% |
2023-02-17 | TRUIST FINANCIAL CORP | added | 0.49 | 251,659 | 1,105,660 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | t. rowe price investment management, inc. | 11.1% | 16,368,144 | SC 13G/A | |
Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 7.51% | 11,045,016 | SC 13G/A | |
Feb 08, 2023 | massachusetts financial services co /ma/ | 5.1% | 7,513,039 | SC 13G | |
Jan 31, 2023 | blackrock inc. | 7.6% | 11,118,621 | SC 13G/A | |
Jan 23, 2023 | laukien joerg c | 5.1% | 7,515,769 | SC 13G | |
Feb 14, 2022 | price t rowe associates inc /md/ | 13.7% | 20,854,627 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 7.10% | 10,765,626 | SC 13G/A | |
Feb 09, 2022 | fmr llc | - | 0 | SC 13G/A | |
Feb 04, 2022 | blackrock inc. | 7.2% | 10,844,554 | SC 13G |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 23.45 -69.05% | 28.59 -62.27% | 38.17 -49.62% | 49.41 -34.79% | 57.33 -24.34% |
Current Inflation | 21.47 -71.66% | 25.82 -65.92% | 33.85 -55.33% | 43.25 -42.92% | 49.83 -34.24% |
Very High Inflation | 19.02 -74.90% | 22.48 -70.33% | 28.74 -62.07% | 36.09 -52.37% | 41.19 -45.64% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 01, 2023 | 10-K | Annual Report | |
Feb 22, 2023 | 3/A | Insider Trading | |
Feb 21, 2023 | 8-K | Current Report | |
Feb 14, 2023 | SC 13G/A | Major Ownership Report | |
Feb 09, 2023 | 8-K | Current Report | |
Feb 09, 2023 | SC 13G/A | Major Ownership Report | |
Feb 09, 2023 | SC 13G/A | Major Ownership Report | |
Feb 08, 2023 | SC 13G | Major Ownership Report | |
Jan 31, 2023 | SC 13G/A | Major Ownership Report | |
Jan 23, 2023 | SC 13G | Major Ownership Report |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-01-17 | Friend Cynthia M | sold | -62,867 | 68.26 | -921 | - |
2023-01-05 | PACKER RICHARD A | acquired | - | - | 1,970 | - |
2023-01-05 | Kastner Marc A | acquired | - | - | 1,970 | - |
2023-01-05 | ORNELL JOHN A | acquired | - | - | 1,970 | - |
2023-01-05 | Ma Philip | acquired | - | - | 1,970 | - |
2023-01-05 | Friend Cynthia M | acquired | - | - | 1,970 | - |
2023-01-05 | Perkins Adelene Q | acquired | - | - | 1,970 | - |
2023-01-05 | Anderson Bonnie H | acquired | - | - | 1,970 | - |
2023-01-05 | Requardt Hermann Fritz | acquired | - | - | 1,970 | - |
2023-01-05 | LINTON WILLIAM A | acquired | - | - | 1,970 | - |
CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME - USD ($) $ in Millions | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Total revenue | $ 2,530.7 | $ 2,417.9 | $ 1,987.5 |
Total cost of revenue | 1,225.0 | 1,208.3 | 1,047.7 |
Gross profit | 1,305.7 | 1,209.6 | 939.8 |
Operating expenses: | |||
Selling, general and administrative | 607.4 | 561.2 | 468.6 |
Research and development | 235.9 | 220.8 | 198.0 |
Other charges, net | 29.7 | 14.3 | 24.9 |
Total operating expenses | 873.0 | 796.3 | 691.5 |
Operating income | 432.7 | 413.3 | 248.3 |
Interest and other income (expense), net | (18.8) | (19.7) | (22.5) |
Income before income taxes, equity in income of unconsolidated investees, net of tax, and noncontrolling interests in consolidated subsidiaries | 413.9 | 393.6 | 225.8 |
Income tax provision | 116.4 | 113.0 | 64.4 |
Equity in income of unconsolidated investees, net of tax | 1.0 | 0.0 | 0.0 |
Consolidated net income | 298.5 | 280.6 | 161.4 |
Net income attributable to noncontrolling interests in consolidated subsidiaries | 1.9 | 3.5 | 3.6 |
Net income attributable to Bruker Corporation | $ 296.6 | $ 277.1 | $ 157.8 |
Net income per common share attributable to Bruker Corporation shareholders: | |||
Basic (in dollars per share) | $ 2.00 | $ 1.83 | $ 1.03 |
Diluted (in dollars per share) | $ 1.99 | $ 1.81 | $ 1.02 |
Weighted average common shares outstanding: | |||
Basic (in shares) | 148.6 | 151.4 | 153.4 |
Diluted (in shares) | 149.4 | 152.9 | 154.6 |
Consolidated net income | $ 298.5 | $ 280.6 | $ 161.4 |
Foreign currency translation adjustments (net of tax of $1.4, $2.1 million and $1.2, respectively) | (67.4) | (77.8) | 97.4 |
Derivatives designated as hedging instruments (net of tax of ($13.8) , $12.5 , respectively) | 44.2 | 51.4 | (75.8) |
Pension liability adjustments (net of tax of ($11.8) , ($3.9) and ($1.7) , respectively) | 45.0 | 14.5 | 7.5 |
Comprehensive income | 320.3 | 268.7 | 190.5 |
Less: Comprehensive income attributable to noncontrolling interests | 1.6 | 1.0 | 4.0 |
Less: Comprehensive loss attributable to redeemable noncontrolling interest | (0.9) | (0.1) | (0.5) |
Comprehensive income attributable to Bruker Corporation | 319.6 | 267.8 | 187.0 |
Product | |||
Total revenue | 2,109.9 | 2,017.3 | 1,638.1 |
Total cost of revenue | 984.0 | 979.3 | 840.2 |
Service | |||
Total revenue | 414.6 | 393.2 | 343.4 |
Total cost of revenue | 240.8 | 228.2 | 206.5 |
Other | |||
Total revenue | 6.2 | 7.4 | 6.0 |
Total cost of revenue | $ 0.2 | $ 0.8 | $ 1.0 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 645.5 | $ 1,068.2 |
Short-term investments | 0.0 | 100.0 |
Accounts receivable, net | 472.7 | 416.9 |
Inventories | 800.1 | 710.1 |
Assets held for sale | 1.4 | 4.4 |
Other current assets | 193.5 | 172.2 |
Total current assets | 2,113.2 | 2,471.8 |
Property, plant and equipment, net | 487.0 | 406.1 |
Goodwill | 457.6 | 339.5 |
Intangible assets, net | 270.9 | 211.8 |
Operating lease assets | 51.2 | 59.9 |
Deferred tax assets | 76.8 | 90.1 |
Other long-term assets | 155.1 | 70.8 |
Total assets | 3,611.8 | 3,650.0 |
Current liabilities: | ||
Current portion of long-term debt and finance lease obligations | 18.7 | 112.4 |
Accounts payable | 178.4 | 147.4 |
Customer advances | 218.0 | 197.5 |
Other current liabilities | 499.2 | 481.2 |
Total current liabilities | 914.3 | 938.5 |
Long-term debt | 1,200.5 | 1,221.8 |
Long-term deferred revenue | 56.2 | 50.2 |
Deferred tax liabilities | 62.3 | 46.0 |
Operating lease liabilities | 34.8 | 41.8 |
Accrued pension | 45.7 | 104.7 |
Other long-term liabilities | 166.2 | 162.2 |
Commitments And Contingencies | ||
Redeemable noncontrolling interests | 6.1 | 0.2 |
Shareholders' equity: | ||
Preferred stock, $0.01 par value 5,000,000 shares authorized, none issued or outstanding at December 31, 2022 and 2021 | 0.0 | 0.0 |
Common stock, $0.01 par value 260,000,000 shares authorized, 175,389,586 and 174,905,035 shares issued and 147,023,144 and 150,753,687 outstanding at December 31, 2022 and 2021, respectively | 1.7 | 1.7 |
Treasury stock at cost, 28,366,442 and 24,151,348 shares at December 31, 2022 and 2021, respectively | (1,085.0) | (820.3) |
Additional paid-in capital | 256.3 | 237.8 |
Retained earnings | 1,926.0 | 1,659.5 |
Accumulated other comprehensive income (loss), net of tax | 14.8 | (8.2) |
Total shareholders' equity attributable to Bruker Corporation | 1,113.8 | 1,070.5 |
Noncontrolling interests in consolidated subsidiaries | 11.9 | 14.1 |
Total shareholders' equity | 1,125.7 | 1,084.6 |
Total liabilities, redeemable noncontrolling interest and shareholders' equity | $ 3,611.8 | $ 3,650.0 |